American Vanguard (NYSE:AVD) Stock Crosses Above 200-Day Moving Average – Should You Sell?

American Vanguard Co. (NYSE:AVD)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.91 and traded as high as $6.25. American Vanguard shares last traded at $6.20, with a volume of 216,179 shares traded.

American Vanguard Stock Performance

The stock has a market capitalization of $178.58 million, a PE ratio of -6.02 and a beta of 0.91. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.89 and a quick ratio of 0.79. The business’s fifty day moving average price is $5.21 and its 200-day moving average price is $5.91.

Insider Transactions at American Vanguard

In related news, Director Steven D. Macicek acquired 12,000 shares of the firm’s stock in a transaction that occurred on Friday, November 15th. The shares were bought at an average cost of $5.97 per share, for a total transaction of $71,640.00. Following the completion of the transaction, the director now owns 31,218 shares in the company, valued at approximately $186,371.46. This trade represents a 62.44 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 10.10% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. SG Americas Securities LLC bought a new position in shares of American Vanguard in the third quarter worth approximately $56,000. Quantbot Technologies LP increased its position in American Vanguard by 64.5% during the 3rd quarter. Quantbot Technologies LP now owns 11,291 shares of the basic materials company’s stock valued at $60,000 after purchasing an additional 4,429 shares during the period. Quantinno Capital Management LP bought a new position in American Vanguard in the 3rd quarter worth $89,000. XTX Topco Ltd bought a new stake in shares of American Vanguard during the 3rd quarter valued at about $104,000. Finally, PDT Partners LLC purchased a new position in shares of American Vanguard during the third quarter valued at about $130,000. 79.04% of the stock is currently owned by institutional investors.

About American Vanguard

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.